2 charged with fentanyl distribution after FIT student's death
Two young men were arraigned Wednesday for fentanyl distribution conspiracy after a student at the Fashion Institute of Technology was fatally poisoned and another nearly died.
The charges against Moises Freire, 19, and Brian Peralta Cabrera, 18, carry a mandatory minimum sentence of 20 years in prison.
Freire was brought into the courtroom in a tan jumpsuit. His handcuffs were removed. Neither defendant acknowledged each other.
Both men pleaded not guilty.
Federal investigators say the deadly incident happened in March inside a dormitory on the FIT campus in Manhattan.
Prosecutors said Freire supplied fentanyl disguised as cocaine to two female students at the college. Cabrera is accused of supplying Freire with the drugs.
Freire had allegedly taken the same drugs a week earlier and called it "poison," saying it was not cocaine. Despite that, he still brought the drugs to the women's dorm and told them it was "pure coke," authorities said.
According to the federal indictment, both women lost consciousness almost immediately after taking the drug. Freire is accused of raping one of the women while she was incapacitated. According to the indictment, he took photos of the unconscious women and sent them to others, and waited 45 minutes before seeking help.
He allegedly originally told campus security the two women consumed too much alcohol.
The students were taken to hospitals, and toxicology testing later confirmed the women ingested fentanyl, prosecutors said.
One student survived, but the other later died from complications of acute fentanyl intoxication, according to investigators.
While leaving federal court Wednesday, Cabrera initially said he had no comment.
CBS News New York's Lisa Rozner asked Cabrera if there was anything he wanted to say about the student who died.
"That may she rest in peace and condolences to the family," he said.
Rozner asked if there was anything he wanted the surviving victim to know.
"That she recovers well," Cabrera said.
The trial is expected to begin in March 2027.